Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent

Annals of Oncology

Volumn 21, Issue 2, 2010, Pages 397-402

  Anaya, D A ^a   Lahat, G ^b   Wang, X ^b   Xiao, L ^b   Pisters, P W ^b   Cormier, J N ^b   Hunt, K K ^b   Feig, B W ^b   Lev, D C ^b   Pollock, R E ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Postoperative nomogram; Prognosis; Retroperitoneal sarcoma; Staging

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; OVERALL SURVIVAL; PATIENT ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROPERITONEAL SARCOMA; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME; ADOLESCENT; EVALUATION; MIDDLE AGED; MORTALITY; RETROPERITONEAL TUMOR; SARCOMA; STATISTICAL MODEL; SURVIVAL; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NOMOGRAMS; POSTOPERATIVE PERIOD; RETROPERITONEAL NEOPLASMS; SARCOMA; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 77951886389     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp298     Document Type: Article

References (30)

1. Kotilingam D, Lev DC, Lazar AJ, Pollock RE. Staging soft tissue sarcoma: evolution and change. CA Cancer J Clin 2006; 56: 282-291; quiz 314-315.
2. Mendenhall WM, Zlotecki RA, Hochwald SN et al. Retroperitoneal soft tissue sarcoma. Cancer 2005; 104: 669-675.
3. Katz MH, Choi EA, Pollock RE. Current concepts in multimodality therapy for retroperitoneal sarcoma. Expert Rev Anticancer Ther 2007; 7: 159-168.
4. Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998; 228: 355-365.
5. Stoeckle E, Coindre JM, Bonvalot S et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 2001; 92: 359-368.
6. Gronchi A, Casali PG, Fiore M et al. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer 2004; 100: 2448-2455.
7. van Dalen T, Hoekstra HJ, van Geel AN et al. Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients. Eur J Surg Oncol 2001; 27: 564-568.
8. van Dalen T, Hennipman A, Van Coevorden F et al. Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal softtissue sarcoma. Ann Surg Oncol 2004; 11: 483-490.
9. Greene FL, Fritz A, Balch CM et al. AJCC Cancer Staging Manual, 6th edition. NY: Springer 2002.
10. Pisters PW, Leung DH, Woodruff J et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996; 14: 1679-1689.
11. Brennan MF. Staging of soft tissue sarcomas. Ann Surg Oncol 1999; 6: 8-9.
12. Lahat G, Tuvin D, Wei C et al. New perspectives for staging and prognosis in soft tissue sarcoma. Ann Surg Oncol 2008; 15: 2739-2748.
13. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 2002; 20: 791-796.
14. Eilber FC, Brennan MF, Eilber FR et al. Validation of the postoperative nomogram for 12-year sarcoma-specific mortality. Cancer 2004; 101: 2270-2275.
15. Fletcher CD. The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology 2006; 48: 3-12.
16. Evans HL. Liposarcoma: a study of 55 cases with a reassessment of its classification. Am J Surg Pathol 1979; 3: 507-523.
17. Evans HL. Atypical lipomatous tumor, its variants, and its combined forms: a study of 61 cases, with a minimum follow-up of 10 years. Am J Surg Pathol 2007; 31: 1-14.
18. Lahat G, Anaya DA, Wang X et al. Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches. Ann Surg Oncol 2008; 15: 1585-1593.
19. Dalal KM, Kattan MW, Antonescu CR et al. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg 2006; 244: 381-391.
20. Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 2003; 238: 358-370; discussion 370-1351.
21. Anaya DA, Lahat G, Wang X et al. Establishing prognosis in retroperitoneal sarcoma: a new histology-based paradigm. Ann Surg Oncol 2009; 16(3): 667-675.
22. Coindre JM. Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med 2006; 130: 1448-1453.
23. Eastham JA, Kattan MW, Scardino PT. Nomograms as predictive models. Semin Urol Oncol 2002; 20: 108-115.
24. Ballo MT, Zagars GK, Pollock RE et al. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys 2007; 67: 158-163.
25. Kattan MW, Karpeh MS, Mazumdar M, Brennan MF. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol 2003; 21: 3647-3650.
26. Brennan MF, Kattan MW, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 2004; 240: 293-298.
27. Cho CS, Gonen M, Shia J et al. A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma. J Am Coll Surg 2008; 206: 281-291.
28. Heslin MJ, Lewis JJ, Nadler E et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol 1997; 15: 2832-2839.
29. Ramanathan RC, A'Hern R, Fisher C, Thomas JM. Modified staging system for extremity soft tissue sarcomas. Ann Surg Oncol 1999; 6: 57-69.
30. Anaya DA, Lahat G, Liu J et al. Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making. Ann Surg 2009; 249: 137-142.